Fish intake lowered the risk for macroalbuminuria and kidney disease in patients with diabetes, according to the results of a cross-sectional study.

Struggling for years to launch a new drug, Eli Lilly and Co. suffered yet another setback when its partners said Tuesday that federal regulators rejected data for a long-acting version of the diabetes drug Byetta.

Neither vitamin E nor vitamin C supplements reduced the risk of major cardiovascular events in a large, long-term study of male physicians, according to a new study.

Mislabeled insulin syringes can cause patients to get 2.5 times more insulin then expected.

They’re more than twice as likely to die sooner, study finds. Having diabetes or high blood pressure may hasten the death of people with Alzheimer’s disease, new research suggests.

A Ph.D. student at Sydney’s Garvan Institute of Medical Research has uncovered an important piece in the puzzle of how insulin works, a problem that has plagued researchers for more than 50 years. The research brings scientists one step closer to explaining exactly how insulin prompts fat and muscle cells …

A study demonstrates that a synthetic new chemical entity protects against diet-induced obesity, improves glucose tolerance and insulin sensitivity and enhances exercise endurance by enhancing fat utilization in certain target tissues.

Acarbose, an alpha-glucosidase inhibitor, improves hyperinsulinemia in overweight women with polycystic ovarian syndrome (PCOS), according to a report in the October issue of Fertility and Sterility.

Tuesday’s election of Democrat Barack Obama ushers in a new administration that is all but certain to include some level of health care reform. Less clear is how extensive that reform will be and when it will come. Hopefully prevention will be a key component in any new changes.

An energy-restricted, high-monounsaturated fat (MUFA) diet is as effective as a high-carbohydrate (CHO), low-fat diet in persons with type 2 diabetes, according to the results of a study.